Nebulized Budesonide for moderate-to-severe croup

Type: drug

Status: FDA Approved (for asthma, off-label use for croup is common and evidence-based)

Developer: Multiple pharmaceutical companies

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026